Publication:
Effects of Recombinant Activated Protein C Derived From Drotrecogin-Alpha on Bleomycin-Induced Pulmonary Fibrosis in Rats Compared with Methyl-Prednisolone

Simple item page
dc.contributor.authorYildiz, Kadir
dc.contributor.authorIraz, Mustafa
dc.contributor.authorŞAMDANCI, EMİNE
dc.contributor.authorÖZEROL, ELİF
dc.contributor.authorKUKU, İRFAN
dc.contributor.authorAYTEMUR, ZEYNEP AYFER
dc.contributor.authorHACIEVLİYAGİL, SÜLEYMAN SAVAŞ
dc.date.accessioned2020-10-22T21:36:36Z
dc.date.available2020-10-22T21:36:36Z
dc.date.issued2013-04-01T00:00:00Z
dc.description.abstractOBJECTIVE: In this study, we aimed to test the preventive effects of intraperitoneally administered drotrecogin alpha which is derived from activated protein C (APC), on bleomycin-induced pulmonary fibrosis in rats, and to compare the effects of APC with the effects of methyl-prednisolone, a traditional therapy.
dc.identifier.citationYildiz K., Iraz M., ŞAMDANCI E., ÖZEROL E., KUKU İ., AYTEMUR Z. A. , HACIEVLİYAGİL S. S. , -Effects of Recombinant Activated Protein C Derived From Drotrecogin-Alpha on Bleomycin-Induced Pulmonary Fibrosis in Rats Compared with Methyl-Prednisolone-, TURKISH THORACIC JOURNAL, cilt.14, ss.48-52, 2013
dc.identifier.doi10.5152/ttd.2013.10
dc.identifier.scopus84875683483
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24871
dc.identifier.wosWOS:000421761000003
dc.titleEffects of Recombinant Activated Protein C Derived From Drotrecogin-Alpha on Bleomycin-Induced Pulmonary Fibrosis in Rats Compared with Methyl-Prednisolone
dc.typeArticle
dspace.entity.typePublication
local.avesis.idf18ba1f3-ec8e-4391-ab8f-dfea0cb6a70d
local.publication.isinternational1
Files
Collections
Yayınlar - Eserler